Omalizumab is well tolerated in adolescent/adult patients (≥12 Years) with moderate-to-severe persistent asthma - Concepedia

Concepedia

Publication | Open Access

Omalizumab is well tolerated in adolescent/adult patients (≥12 Years) with moderate-to-severe persistent asthma

DOI Full Paper Access

16

Citations

0

References

2005

Year

Jonathan Corren, Thomas B. Casale, B.Q. Lanier, Martin Blogg, Colin Reisner, Niroo Gupta

Journal of Allergy and Clinical Immunology

AsthmaAdolescent/adult PatientsAllergyModerate-to-severe Persistent AsthmaAllergy MedicineAllergic RhinitisMedicineClinical Allergy

No additional data available for this publication yet. Check back later!